DENTSPLY SIRONA (XRAY) Financials

$15.47 -0.38 (-2.40%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$15.71 +0.24 (+1.54%)

As of 05/23/2025 04:52 PM Eastern

Annual Income Statements for DENTSPLY SIRONA

This table shows DENTSPLY SIRONA's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-910	-132	-950	411	-73	256	-1,011	-1,550	430	251
Consolidated Net Income / (Loss)	-910	-132	-950	411	-73	256	-1,011	-1,550	431	251
Net Income / (Loss) Continuing Operations	-910	-132	-950	411	-73	256	-1,011	-1,550	431	251
Total Pre-Tax Income	-936	-175	-1,055	545	-50	338	-958	-1,604	441	330
Total Operating Income	-879	-85	-937	608	-3.00	353	-958	-1,562	455	375
Total Gross Profit	1,958	2,086	2,127	2,347	1,656	2,164	2,068	2,189	2,001	1,517
Total Revenue	3,793	3,965	3,922	4,231	3,339	4,022	3,986	3,993	3,745	2,674
Operating Revenue	3,793	3,965	3,922	4,231	3,339	4,022	3,986	3,993	3,745	2,674
Total Cost of Revenue	1,835	1,879	1,795	1,884	1,683	1,858	1,918	1,805	1,744	1,157
Operating Cost of Revenue	1,835	1,879	1,795	1,884	1,683	1,858	1,918	1,805	1,744	1,157
Total Operating Expenses	2,837	2,171	3,064	1,739	1,659	1,811	3,026	3,751	1,546	1,142
Selling, General & Admin Expense	1,605	1,613	1,589	1,551	1,302	1,587	1,719	1,675	1,523	1,077
Research & Development Expense	165	184	174	171	123	143	-	-	-	-
Impairment Charge	1,014	307	1,287	0.00	234	0.00	1,086	1,651	0.00	0.00
Restructuring Charge	53	67	14	17	-	81	221	425	23	65
Total Other Income / (Expense), net	-57	-90	-118	-63	-47	-15	0.00	-41	-14	-46
Interest Expense	69	81	65	61	-	-	37	38	36	56
Other Income / (Expense), net	12	-9.00	-53	-2.00	-1.00	12	35	-5.30	20	8.20
Income Tax Expense	-26	-43	-105	134	23	82	53	-53	9.50	77
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.30	1.50	-0.10
Basic Earnings per Share	($4.48)	($0.62)	($4.41)	$1.88	($0.33)	$1.15	($4.51)	($6.76)	$1.97	$1.79
Weighted Average Basic Shares Outstanding	203.20M	212M	215.50M	218.40M	219.20M	223.10M	224.30M	229.40M	218M	140M
Diluted Earnings per Share	($4.48)	($0.62)	($4.41)	$1.87	($0.33)	$1.14	($4.51)	($6.76)	$1.94	$1.76
Weighted Average Diluted Shares Outstanding	203.20M	212M	215.50M	220.20M	219.20M	224.40M	224.30M	229.40M	221.60M	142.70M
Weighted Average Basic & Diluted Shares Outstanding	198.99M	207.36M	215.36M	217.55M	219.05M	221.44M	224.20M	229.30M	218.20M	140.30M
Cash Dividends to Common per Share	$0.64	$0.56	$0.50	$0.43	$0.40	$0.38	$0.35	$0.35	$0.31	$0.29

This table shows DENTSPLY SIRONA's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	20	-430	-494	-4.00	18	67	-266	86	-19	-15	-1,077
Consolidated Net Income / (Loss)	19	-428	-495	-4.00	17	72	-266	85	-23	-15	-1,077
Net Income / (Loss) Continuing Operations	19	-428	-495	-4.00	17	72	-266	85	-23	-15	-1,077
Total Pre-Tax Income	44	-523	-478	34	31	57	-250	46	-28	8.00	-1,241
Total Operating Income	63	-509	-462	50	42	73	-236	80	-2.00	65	-1,218
Total Gross Profit	466	446	495	511	506	522	495	550	519	517	508
Total Revenue	879	905	951	984	953	1,012	947	1,028	978	983	947
Operating Revenue	879	905	951	984	953	1,012	947	1,028	978	983	947
Total Cost of Revenue	413	459	456	473	447	490	452	478	459	466	439
Operating Cost of Revenue	413	459	456	473	447	490	452	478	459	466	439
Total Operating Expenses	403	955	957	461	464	449	731	470	521	452	1,726
Selling, General & Admin Expense	358	401	390	399	415	409	372	416	416	402	401
Research & Development Expense	36	42	40	41	42	43	46	49	46	43	41
Impairment Charge	0.00	504	504	0.00	6.00	-	307	0.00	0.00	-	1,281
Restructuring Charge	9.00	8.00	23	21	1.00	-3.00	6.00	5.00	59	1.00	3.00
Total Other Income / (Expense), net	-19	-14	-16	-16	-11	-16	-14	-34	-26	-57	-23
Interest Expense	19	16	18	17	18	20	19	22	20	24	14
Other Income / (Expense), net	0.00	2.00	2.00	1.00	7.00	4.00	5.00	-12	-6.00	-33	-9.00
Income Tax Expense	25	-95	17	38	14	-15	16	-39	-5.00	23	-164
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.00	2.00	-1.00	0.00	-1.00	5.00	0.00	-1.00	-4.00	-	0.00
Basic Earnings per Share	$0.10	($2.09)	($2.46)	($0.02)	$0.09	$0.31	($1.25)	$0.41	($0.09)	($0.06)	($5.01)
Weighted Average Basic Shares Outstanding	199.10M	203.20M	201M	205.60M	207.40M	212M	211.80M	211.90M	214.50M	215.50M	214.90M
Diluted Earnings per Share	$0.10	($2.09)	($2.46)	($0.02)	$0.09	$0.32	($1.25)	$0.40	($0.09)	($0.06)	($5.01)
Weighted Average Diluted Shares Outstanding	199.80M	203.20M	201M	205.60M	208.50M	212M	211.80M	213.10M	214.50M	215.50M	214.90M
Weighted Average Basic & Diluted Shares Outstanding	199.29M	198.99M	198.78M	202.71M	207.63M	207.36M	211.86M	211.72M	212.48M	215.36M	214.91M
Cash Dividends to Common per Share	$0.16	-	$0.16	$0.16	$0.16	-	$0.14	$0.14	$0.14	-	$0.13

This table details how cash moves in and out of DENTSPLY SIRONA's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-62	-31	26	-99	33	95	-3.00	-63	99	133
Net Cash From Operating Activities	461	377	517	657	649	639	500	602	563	497
Net Cash From Continuing Operating Activities	461	377	517	657	649	639	500	602	563	497
Net Income / (Loss) Continuing Operations	-910	-132	-950	411	-73	256	-1,011	-1,550	431	251
Consolidated Net Income / (Loss)	-910	-132	-950	411	-73	256	-1,011	-1,550	431	251
Depreciation Expense	133	132	119	124	142	133	133	127	117	79
Amortization Expense	216	211	209	222	192	190	201	192	160	55
Non-Cash Adjustments To Reconcile Net Income	1,063	352	1,445	51	250	116	1,273	2,122	9.10	47
Changes in Operating Assets and Liabilities, net	-41	-186	-306	-151	138	-56	-96	-289	-153	66
Net Cash From Investing Activities	-197	-89	-138	-358	-1,106	-69	-253	-286	60	-55
Net Cash From Continuing Investing Activities	-197	-89	-138	-358	-1,106	-69	-253	-286	60	-55
Purchase of Property, Plant & Equipment	-180	-149	-149	-142	-87	-123	-183	-144	-125	-72
Purchase of Investments	-12	0.00	0.00	-	-	-	-6.00	-2.50	-24	-6.30
Divestitures	0.00	13	0.00	28	1.00	11	0.00	0.00	528	0.00
Sale and/or Maturity of Investments	1.00	39	13	2.00	58	40	62	6.50	20	78
Other Investing Activities, net	-6.00	8.00	-2.00	2.00	0.00	6.00	-	-0.90	-1.70	-1.40
Net Cash From Financing Activities	-302	-307	-329	-379	476	-472	-250	-401	-526	-303
Net Cash From Continuing Financing Activities	-302	-307	-329	-379	476	-472	-250	-401	-526	-303
Repayment of Debt	-104	-17	-81	-154	-727	-360	-9.00	-17	-922	-270
Repurchase of Common Equity	-250	-300	-150	-200	-140	-260	-250	-401	-814	-113
Payment of Dividends	-126	-116	-104	-92	-88	-81	-79	-78	-65	-40
Issuance of Debt	178	126	6.00	16	1,450	120	60	13	1,221	153
Effect of Exchange Rate Changes	-24	-	-24	-19	-	-3.00	-	-	2.10	-6.60
Cash Interest Paid	91	97	70	64	45	30	35	37	37	55
Cash Income Taxes Paid	74	177	122	148	82	112	105	123	112	71

This table details how cash moves in and out of DENTSPLY SIRONA's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	126	-24	17	-12	-43	25	14	-23	-47	-53	56
Net Cash From Operating Activities	7.00	87	141	208	25	160	134	104	-21	142	109
Net Cash From Continuing Operating Activities	7.00	87	141	208	25	160	134	104	-21	142	109
Net Income / (Loss) Continuing Operations	19	-428	-495	-4.00	17	72	-266	85	-23	-15	-1,077
Consolidated Net Income / (Loss)	19	-428	-495	-4.00	17	72	-266	85	-23	-15	-1,077
Depreciation Expense	34	34	35	32	32	33	35	33	31	29	31
Amortization Expense	45	54	54	54	54	52	53	53	53	50	51
Non-Cash Adjustments To Reconcile Net Income	19	482	514	31	36	-17	302	-11	78	84	1,302
Changes in Operating Assets and Liabilities, net	-110	-55	33	95	-114	20	10	-56	-160	-6.00	-198
Net Cash From Investing Activities	-17	-57	-47	-50	-43	-20	-2.00	-30	-37	-29	-26
Net Cash From Continuing Investing Activities	-17	-57	-47	-50	-43	-20	-2.00	-30	-37	-29	-26
Purchase of Property, Plant & Equipment	-19	-51	-43	-52	-34	-40	-37	-33	-39	-32	-32
Purchase of Investments	0.00	-	-3.00	-	-9.00	-	-	-	0.00	-	-
Sale of Property, Plant & Equipment	1.00	-	-	-	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	1.00	1.00	-1.00	1.00	0.00	-	35	2.00	2.00	3.00	5.00
Net Cash From Financing Activities	123	-38	-79	-171	-14	-128	-109	-87	17	-161	-6.00
Net Cash From Continuing Financing Activities	123	-38	-79	-171	-14	-128	-109	-87	17	-161	-6.00
Repayment of Debt	-280	-86	-2.00	-8.00	-8.00	-4.00	-7.00	-2.00	-4.00	-64	-7.00
Payment of Dividends	-32	-31	-33	-33	-29	-30	-29	-30	-27	-26	-27
Issuance of Debt	435	79	56	20	23	56	-73	-55	198	-65	28
Other Net Changes in Cash	13	-	-	-	-	-	-	-	-6.00	-	-
Cash Interest Paid	13	-	-	-	-	-	-	-	-	-	-

This table presents DENTSPLY SIRONA's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	5,753	7,370	7,643	9,239	9,350	8,603	8,687	10,375	11,556	4,403
Total Current Assets	1,746	1,973	1,893	1,852	1,798	2,000	1,888	2,003	1,744	1,197
Cash & Equivalents	272	334	365	339	438	405	310	321	384	285
Note & Lease Receivable	556	695	632	750	667	782	702	746	636	400
Inventories, net	564	624	627	515	476	562	599	623	517	340
Prepaid Expenses	354	320	269	248	217	251	278	313	207	172
Plant, Property, & Equipment, net	766	800	761	773	791	802	871	876	800	559
Total Noncurrent Assets	3,241	4,597	4,989	6,614	6,761	5,801	5,928	7,496	9,013	2,647
Goodwill	1,597	2,438	2,688	3,976	3,986	3,397	3,431	4,539	5,952	1,988
Intangible Assets	1,207	1,705	1,903	2,319	2,504	2,176	2,420	2,801	2,958	601
Other Noncurrent Operating Assets	437	454	398	319	271	228	77	156	103	59
Total Liabilities & Shareholders' Equity	5,753	7,370	7,643	9,239	9,350	8,603	8,687	10,375	11,556	4,403
Total Liabilities	3,810	4,076	3,831	4,242	4,415	3,508	3,554	3,747	3,430	2,064
Total Current Liabilities	1,589	1,425	1,170	1,261	1,372	995	1,013	955	768	476
Short-Term Debt	549	322	118	182	299	2.00	92	30	21	12
Accounts Payable	241	305	279	262	302	308	284	284	223	134
Accrued Expenses	754	749	727	760	712	629	579	586	463	310
Current Deferred & Payable Income Tax Liabilities	45	49	46	57	59	56	58	54	61	20
Total Noncurrent Liabilities	2,221	2,651	2,661	2,981	3,043	2,513	2,541	2,792	2,662	1,588
Long-Term Debt	1,586	1,796	1,826	1,913	1,978	1,433	1,565	1,612	1,511	1,141
Noncurrent Deferred & Payable Income Tax Liabilities	129	228	287	391	381	480	553	718	752	160
Other Noncurrent Operating Liabilities	506	627	548	677	684	600	423	463	400	286
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,943	3,294	3,812	4,997	4,935	5,095	5,133	6,628	8,126	2,339
Total Preferred & Common Equity	1,942	3,293	3,811	4,996	4,932	5,093	5,121	6,616	8,114	2,338
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,942	3,293	3,811	4,996	4,932	5,093	5,121	6,616	8,114	2,338
Common Stock	6,643	6,646	6,632	6,609	6,607	6,590	6,525	6,547	6,519	239
Retained Earnings	-835	205	456	1,514	1,198	1,404	1,226	2,316	3,948	3,591
Treasury Stock	-3,136	-2,922	-2,649	-2,535	-2,409	-2,301	-2,151	-1,955	-1,647	-898
Accumulated Other Comprehensive Income / (Loss)	-730	-636	-628	-592	-464	-600	-479	-291	-706	-594
Noncontrolling Interest	1.00	1.00	1.00	1.00	3.00	2.00	12	12	12	1.40

This table presents DENTSPLY SIRONA's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	6,050	6,626	6,897	7,123	7,201	7,650	7,673	7,522
Total Current Assets	1,978	1,921	1,758	1,902	1,913	1,920	1,943	1,939
Cash & Equivalents	398	296	279	291	309	295	318	418
Note & Lease Receivable	604	671	591	656	649	670	652	645
Inventories, net	612	619	608	613	651	657	659	592
Prepaid Expenses	364	335	280	342	304	298	314	284
Plant, Property, & Equipment, net	791	817	789	782	753	772	770	714
Total Noncurrent Assets	3,281	3,888	4,350	4,439	4,535	4,958	4,960	4,869
Goodwill	1,632	1,937	2,389	2,400	2,374	2,703	2,701	2,584
Intangible Assets	1,212	1,538	1,559	1,618	1,711	1,808	1,862	1,875
Other Noncurrent Operating Assets	437	413	402	421	450	447	397	410
Total Liabilities & Shareholders' Equity	6,050	6,626	6,897	7,123	7,201	7,650	7,673	7,522
Total Liabilities	4,040	4,136	3,833	3,865	3,830	3,948	4,035	3,908
Total Current Liabilities	1,793	1,542	1,323	1,330	1,218	1,271	1,374	1,296
Short-Term Debt	742	422	362	343	187	261	316	246
Accounts Payable	276	297	287	279	262	265	267	271
Accrued Expenses	738	798	650	681	732	728	748	711
Current Deferred & Payable Income Tax Liabilities	37	25	24	27	37	17	43	68
Total Noncurrent Liabilities	2,247	2,594	2,510	2,535	2,612	2,677	2,661	2,612
Long-Term Debt	1,593	1,795	1,737	1,747	1,803	1,841	1,842	1,737
Noncurrent Deferred & Payable Income Tax Liabilities	134	193	194	214	249	261	271	246
Other Noncurrent Operating Liabilities	520	606	579	574	560	575	548	629
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,010	2,490	3,064	3,258	3,371	3,702	3,638	3,614
Total Preferred & Common Equity	2,010	2,491	3,064	3,258	3,375	3,706	3,641	3,613
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,010	2,491	3,064	3,258	3,375	3,706	3,641	3,613
Common Stock	6,634	6,642	6,634	6,642	6,648	6,651	6,607	6,622
Retained Earnings	-848	-374	152	190	167	463	407	498
Treasury Stock	-3,117	-3,139	-3,045	-2,908	-2,783	-2,788	-2,759	-2,663
Accumulated Other Comprehensive Income / (Loss)	-659	-638	-677	-666	-657	-620	-614	-844
Noncontrolling Interest	0.00	-1.00	0.00	0.00	-4.00	-4.00	-3.00	1.00

This table displays calculated financial ratios and metrics derived from DENTSPLY SIRONA's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.34%	1.10%	-7.30%	26.71%	-16.98%	0.90%	-0.19%	6.62%	40.05%	-8.50%
EBITDA Growth	-308.03%	137.61%	-169.54%	188.48%	-52.03%	216.81%	52.83%	-266.26%	45.09%	-10.67%
EBIT Growth	-822.34%	90.51%	-263.37%	15,250.00%	-101.10%	139.55%	41.12%	-430.16%	23.84%	-13.98%
NOPAT Growth	-934.12%	90.93%	-243.05%	21,933.81%	-100.79%	139.87%	38.68%	-345.81%	54.71%	-19.27%
Net Income Growth	-589.39%	86.11%	-331.14%	663.01%	-128.52%	125.32%	34.79%	-459.36%	71.80%	-22.24%
EPS Growth	-622.58%	85.94%	-335.83%	666.67%	-128.95%	125.28%	33.28%	-448.45%	10.23%	-21.43%
Operating Cash Flow Growth	22.28%	-27.08%	-21.31%	1.23%	1.56%	27.80%	-16.93%	6.83%	13.27%	-11.24%
Free Cash Flow Firm Growth	159.05%	-64.10%	47.25%	173.65%	-204.50%	-21.89%	244.44%	104.12%	-1,197.56%	-43.27%
Invested Capital Growth	-25.05%	-5.81%	-20.17%	-0.31%	10.60%	-5.49%	-18.47%	-14.29%	189.11%	-6.54%
Revenue Q/Q Growth	-2.74%	0.74%	-2.97%	0.28%	-0.40%	1.13%	-0.79%	2.42%	9.51%	-1.76%
EBITDA Q/Q Growth	-922.22%	25.76%	-28.79%	1.60%	10.55%	7.35%	57.19%	-204.09%	12.34%	-0.32%
EBIT Q/Q Growth	-206.36%	32.37%	-16.75%	2.89%	83.94%	15.73%	46.13%	-116.94%	10.03%	-1.92%
NOPAT Q/Q Growth	-195.96%	8.60%	-12.89%	1.58%	89.40%	53.99%	45.14%	-116.48%	7.15%	-5.32%
Net Income Q/Q Growth	-121.95%	39.73%	-16.42%	0.98%	21.17%	58.02%	39.19%	-95.70%	12.90%	-9.40%
EPS Q/Q Growth	-116.43%	38.00%	-16.05%	1.63%	21.43%	62.86%	38.47%	-92.05%	0.00%	-9.74%
Operating Cash Flow Q/Q Growth	-13.67%	5.01%	-13.40%	-6.01%	-6.01%	19.24%	-5.03%	1.09%	20.54%	-11.76%
Free Cash Flow Firm Q/Q Growth	51.63%	309.53%	-35.69%	169.47%	-227.07%	8.20%	-8.17%	-36.64%	6.27%	-34.58%
Invested Capital Q/Q Growth	-13.72%	0.51%	4.09%	-1.53%	18.50%	-1.98%	-2.56%	-9.07%	-3.52%	0.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.62%	52.61%	54.23%	55.47%	49.60%	53.80%	51.88%	54.80%	53.42%	56.73%
EBITDA Margin	-13.66%	6.28%	-16.88%	22.50%	9.88%	17.11%	-14.78%	-31.27%	20.05%	19.35%
Operating Margin	-23.17%	-2.14%	-23.89%	14.37%	-0.09%	8.78%	-24.03%	-39.12%	12.14%	14.03%
EBIT Margin	-22.86%	-2.37%	-25.24%	14.32%	-0.12%	9.08%	-23.16%	-39.25%	12.68%	14.34%
Profit (Net Income) Margin	-23.99%	-3.33%	-24.22%	9.71%	-2.19%	6.37%	-25.36%	-38.82%	11.52%	9.39%
Tax Burden Percent	97.22%	75.43%	90.05%	75.41%	146.00%	75.74%	105.53%	96.68%	97.85%	76.16%
Interest Burden Percent	107.96%	186.17%	106.57%	89.93%	1,250.00%	92.60%	103.79%	102.29%	92.86%	85.99%
Effective Tax Rate	0.00%	0.00%	0.00%	24.59%	0.00%	24.26%	0.00%	0.00%	2.15%	23.35%
Return on Invested Capital (ROIC)	-13.85%	-1.14%	-10.80%	6.78%	-0.03%	4.24%	-9.29%	-12.70%	7.13%	8.66%
ROIC Less NNEP Spread (ROIC-NNEP)	-30.01%	-5.45%	-28.44%	4.14%	-4.98%	3.29%	-34.80%	-49.69%	5.79%	4.97%
Return on Net Nonoperating Assets (RNNOA)	-20.90%	-2.58%	-10.77%	1.50%	-1.42%	0.76%	-7.90%	-8.32%	1.12%	2.11%
Return on Equity (ROE)	-34.75%	-3.72%	-21.57%	8.28%	-1.46%	5.01%	-17.19%	-21.02%	8.24%	10.77%
Cash Return on Invested Capital (CROIC)	14.78%	4.84%	11.63%	7.09%	-10.10%	9.89%	11.06%	2.69%	-90.07%	15.43%
Operating Return on Assets (OROA)	-13.21%	-1.25%	-11.73%	6.52%	-0.04%	4.22%	-9.68%	-14.30%	5.95%	8.47%
Return on Assets (ROA)	-13.87%	-1.76%	-11.25%	4.42%	-0.81%	2.96%	-10.61%	-14.14%	5.41%	5.55%
Return on Common Equity (ROCE)	-34.74%	-3.71%	-21.56%	8.27%	-1.45%	5.00%	-17.16%	-20.98%	8.23%	10.77%
Return on Equity Simple (ROE_SIMPLE)	-46.86%	-4.01%	-24.93%	8.23%	-1.48%	5.03%	-19.74%	-23.43%	5.32%	10.74%
Net Operating Profit after Tax (NOPAT)	-615	-60	-656	459	-2.10	267	-671	-1,094	445	288
NOPAT Margin	-16.22%	-1.50%	-16.72%	10.84%	-0.06%	6.65%	-16.82%	-27.39%	11.88%	10.75%
Net Nonoperating Expense Percent (NNEP)	16.16%	4.31%	17.64%	2.64%	4.94%	0.96%	25.51%	36.99%	1.34%	3.69%
Return On Investment Capital (ROIC_SIMPLE)	-15.09%	-1.10%	-11.40%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	48.38%	47.39%	45.77%	44.53%	50.40%	46.20%	48.12%	45.20%	46.58%	43.27%
SG&A Expenses to Revenue	42.31%	40.68%	40.52%	36.66%	38.99%	39.46%	43.13%	41.94%	40.66%	40.28%
R&D to Revenue	4.35%	4.64%	4.44%	4.04%	3.68%	3.56%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	74.80%	54.75%	78.12%	41.10%	49.69%	45.03%	75.92%	93.93%	41.28%	42.70%
Earnings before Interest and Taxes (EBIT)	-867	-94	-990	606	-4.00	365	-923	-1,568	475	383
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-518	249	-662	952	330	688	-589	-1,249	751	518
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.94	2.23	1.72	2.34	2.21	2.33	1.52	2.12	1.52	3.35
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.99	1.85	1.67	2.77	3.27	2.95	1.95	3.52	3.29	2.93
Price to Earnings (P/E)	0.00	0.00	0.00	28.49	0.00	46.42	0.00	0.00	28.67	31.17
Dividend Yield	3.37%	1.61%	1.64%	0.80%	0.80%	0.70%	1.00%	0.57%	0.58%	0.52%
Earnings Yield	0.00%	0.00%	0.00%	3.51%	0.00%	2.15%	0.00%	0.00%	3.49%	3.21%
Enterprise Value to Invested Capital (EV/IC)	1.48	1.80	1.51	1.99	1.88	2.11	1.41	1.94	1.45	2.71
Enterprise Value to Revenue (EV/Rev)	1.49	2.30	2.08	3.18	3.82	3.21	2.29	3.85	3.60	3.25
Enterprise Value to EBITDA (EV/EBITDA)	0.00	36.68	0.00	14.14	38.63	18.77	0.00	0.00	17.95	16.81
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	22.22	0.00	35.38	0.00	0.00	28.40	22.69
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	29.37	0.00	48.30	0.00	0.00	30.31	30.25
Enterprise Value to Operating Cash Flow (EV/OCF)	12.23	24.23	15.76	20.49	19.64	20.21	18.25	25.57	23.93	17.49
Enterprise Value to Free Cash Flow (EV/FCFF)	8.58	36.03	11.54	28.08	0.00	20.73	11.44	66.45	0.00	16.98
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.10	0.64	0.51	0.42	0.46	0.28	0.32	0.25	0.19	0.49
Long-Term Debt to Equity	0.82	0.55	0.48	0.38	0.40	0.28	0.30	0.24	0.19	0.49
Financial Leverage	0.70	0.47	0.38	0.36	0.29	0.23	0.23	0.17	0.19	0.42
Leverage Ratio	2.51	2.11	1.92	1.87	1.79	1.69	1.62	1.49	1.52	1.94
Compound Leverage Factor	2.71	3.93	2.04	1.68	22.37	1.57	1.68	1.52	1.42	1.67
Debt to Total Capital	52.35%	39.14%	33.77%	29.54%	31.57%	21.98%	24.41%	19.85%	15.86%	33.02%
Short-Term Debt to Total Capital	13.46%	5.95%	2.05%	2.57%	4.15%	0.03%	1.36%	0.36%	0.22%	0.35%
Long-Term Debt to Total Capital	38.89%	33.19%	31.72%	26.97%	27.43%	21.94%	23.05%	19.49%	15.65%	32.67%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.02%	0.02%	0.02%	0.01%	0.04%	0.03%	0.18%	0.14%	0.12%	0.04%
Common Equity to Total Capital	47.62%	60.85%	66.21%	70.45%	68.39%	77.99%	75.42%	80.01%	84.02%	66.94%
Debt to EBITDA	-4.12	8.51	-2.94	2.20	6.90	2.09	-2.81	-1.31	2.04	2.23
Net Debt to EBITDA	-3.60	7.16	-2.39	1.84	5.57	1.50	-2.29	-1.06	1.53	1.68
Long-Term Debt to EBITDA	-3.06	7.21	-2.76	2.01	5.99	2.08	-2.66	-1.29	2.01	2.20
Debt to NOPAT	-3.47	-35.60	-2.96	4.57	-1,084.29	5.37	-2.47	-1.50	3.44	4.01
Net Debt to NOPAT	-3.03	-29.98	-2.41	3.83	-875.71	3.85	-2.01	-1.21	2.58	3.02
Long-Term Debt to NOPAT	-2.58	-30.18	-2.78	4.17	-941.90	5.36	-2.33	-1.47	3.40	3.97
Altman Z-Score	0.59	1.71	1.31	2.64	2.07	3.01	1.74	2.57	3.20	4.51
Noncontrolling Interest Sharing Ratio	0.04%	0.03%	0.02%	0.04%	0.05%	0.14%	0.20%	0.16%	0.12%	0.05%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.10	1.38	1.62	1.47	1.31	2.01	1.86	2.10	2.27	2.51
Quick Ratio	0.52	0.72	0.85	0.86	0.81	1.19	1.00	1.12	1.33	1.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	657	254	706	480	-651	623	798	232	-5,621	512
Operating Cash Flow to CapEx	256.11%	253.02%	346.98%	462.68%	745.98%	519.51%	287.36%	439.66%	469.50%	694.69%
Free Cash Flow to Firm to Interest Expense	9.52	3.13	10.86	7.86	0.00	0.00	21.56	6.05	-156.58	9.16
Operating Cash Flow to Interest Expense	6.68	4.65	7.95	10.77	0.00	0.00	13.51	15.72	15.69	8.90
Operating Cash Flow Less CapEx to Interest Expense	4.07	2.81	5.66	8.44	0.00	0.00	8.81	12.14	12.35	7.62
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.53	0.46	0.46	0.37	0.47	0.42	0.36	0.47	0.59
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	3.09	3.00	3.14	3.80	3.24	3.20	3.14	3.17	4.07	3.18
Fixed Asset Turnover	4.84	5.08	5.11	5.41	4.19	4.81	4.56	4.77	5.51	4.66
Accounts Payable Turnover	6.72	6.43	6.64	6.68	5.52	6.28	6.75	7.11	9.78	8.69
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	118.15	121.50	116.11	96.00	112.56	114.03	116.27	115.29	89.71	114.74
Days Payable Outstanding (DPO)	54.30	56.72	55.00	54.63	66.15	58.14	54.07	51.31	37.31	41.99
Cash Conversion Cycle (CCC)	63.85	64.78	61.10	41.36	46.41	55.89	62.20	63.98	52.40	72.76
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,806	5,078	5,391	6,753	6,774	6,125	6,481	7,949	9,274	3,208
Invested Capital Turnover	0.85	0.76	0.65	0.63	0.52	0.64	0.55	0.46	0.60	0.81
Increase / (Decrease) in Invested Capital	-1,272	-313	-1,362	-21	649	-356	-1,468	-1,325	6,066	-225
Enterprise Value (EV)	5,637	9,134	8,148	13,464	12,749	12,915	9,124	15,390	13,484	8,699
Market Capitalization	3,773	7,349	6,568	11,707	10,907	11,883	7,764	14,058	12,324	7,829
Book Value per Share	$9.77	$15.54	$17.73	$22.85	$22.57	$22.90	$23.01	$28.81	$35.15	$16.72
Tangible Book Value per Share	($4.34)	($4.01)	($3.63)	($5.94)	($7.13)	($2.16)	($3.28)	($3.15)	($3.44)	($1.79)
Total Capital	4,078	5,412	5,756	7,092	7,212	6,530	6,790	8,270	9,658	3,493
Total Debt	2,135	2,118	1,944	2,095	2,277	1,435	1,657	1,642	1,532	1,153
Total Long-Term Debt	1,586	1,796	1,826	1,913	1,978	1,433	1,565	1,612	1,511	1,141
Net Debt	1,863	1,784	1,579	1,756	1,839	1,030	1,348	1,321	1,148	869
Capital Expenditures (CapEx)	180	149	149	142	87	123	174	137	120	72
Debt-free, Cash-free Net Working Capital (DFCFNWC)	434	536	476	434	287	602	658	758	613	448
Debt-free Net Working Capital (DFNWC)	706	870	841	773	725	1,007	967	1,078	997	733
Net Working Capital (NWC)	157	548	723	591	426	1,005	875	1,048	976	721
Net Nonoperating Expense (NNE)	295	73	294	48	71	11	340	457	14	36
Net Nonoperating Obligations (NNO)	1,863	1,784	1,579	1,756	1,839	1,030	1,348	1,321	1,148	869
Total Depreciation and Amortization (D&A)	349	343	328	346	334	323	334	319	276	134
Debt-free, Cash-free Net Working Capital to Revenue	11.44%	13.52%	12.14%	10.26%	8.60%	14.97%	16.50%	18.97%	16.37%	16.76%
Debt-free Net Working Capital to Revenue	18.61%	21.94%	21.44%	18.27%	21.71%	25.04%	24.26%	27.00%	26.62%	27.40%
Net Working Capital to Revenue	4.14%	13.82%	18.43%	13.97%	12.76%	24.99%	21.94%	26.24%	26.06%	26.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($4.48)	($0.62)	$0.00	$1.93	($0.38)	$1.18	($4.51)	($6.76)	$1.97	$1.79
Adjusted Weighted Average Basic Shares Outstanding	203.20M	212M	0.00	218.40M	219.20M	223.10M	224.30M	229.40M	218M	140M
Adjusted Diluted Earnings per Share	($4.48)	($0.62)	$0.00	$1.91	($0.38)	$1.17	($4.51)	($6.76)	$1.94	$1.76
Adjusted Weighted Average Diluted Shares Outstanding	203.20M	212M	0.00	220.20M	219.20M	224.40M	224.30M	229.40M	221.60M	142.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	198.99M	207.36M	0.00	217.55M	219.05M	221.44M	223.22M	227.38M	229.68M	140.12M
Normalized Net Operating Profit after Tax (NOPAT)	132	202	255	471	162	329	244	360	468	337
Normalized NOPAT Margin	3.47%	5.10%	6.50%	11.14%	4.84%	8.17%	6.13%	9.01%	12.49%	12.61%
Pre Tax Income Margin	-24.68%	-4.41%	-26.90%	12.88%	-1.50%	8.40%	-24.03%	-40.15%	11.77%	12.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-12.57	-1.16	-15.23	9.93	0.00	0.00	-24.95	-40.93	13.23	6.86
NOPAT to Interest Expense	-8.92	-0.73	-10.09	7.52	0.00	0.00	-18.12	-28.55	12.39	5.14
EBIT Less CapEx to Interest Expense	-15.17	-3.00	-17.52	7.61	0.00	0.00	-29.65	-44.50	9.88	5.58
NOPAT Less CapEx to Interest Expense	-11.53	-2.57	-12.38	5.19	0.00	0.00	-22.83	-32.13	9.05	3.86
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-13.85%	-87.88%	-10.95%	22.38%	-120.55%	31.64%	-7.81%	-5.05%	14.97%	15.93%
Augmented Payout Ratio	-41.32%	-315.15%	-26.74%	71.05%	-312.33%	133.20%	-32.54%	-30.94%	203.64%	60.81%

This table displays calculated financial ratios and metrics derived from DENTSPLY SIRONA's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.77%	-10.57%	0.42%	-4.28%	-2.56%	2.95%	0.00%	0.49%	0.93%	-10.88%	-8.94%
EBITDA Growth	5.19%	-358.64%	-159.44%	-11.04%	77.63%	45.95%	87.51%	-18.52%	-58.47%	-57.14%	-640.09%
EBIT Growth	28.57%	-758.44%	-99.13%	-25.00%	712.50%	140.63%	81.17%	-35.85%	-108.08%	-81.61%	-1,066.14%
NOPAT Growth	18.12%	-486.40%	-95.76%	-103.98%	1,745.16%	175.66%	80.62%	54.85%	-101.82%	-192.89%	-968.90%
Net Income Growth	11.76%	-694.44%	-86.09%	-104.71%	173.91%	580.00%	75.30%	16.44%	-133.33%	-112.61%	-1,382.14%
EPS Growth	11.11%	-753.13%	-96.80%	-105.00%	200.00%	633.33%	75.05%	17.65%	-128.13%	-110.91%	-1,418.42%
Operating Cash Flow Growth	-72.00%	-45.63%	5.22%	100.00%	219.05%	12.68%	22.94%	-39.88%	-122.58%	-36.04%	-36.63%
Free Cash Flow Firm Growth	156.11%	125.98%	931.41%	-45.78%	-63.89%	-67.33%	-104.62%	94.04%	432.45%	714.77%	179.20%
Invested Capital Growth	-21.95%	-25.05%	-12.69%	-11.35%	-7.69%	-5.81%	-2.45%	-15.29%	-18.35%	-20.17%	-24.48%
Revenue Q/Q Growth	-2.87%	-4.84%	-3.35%	3.25%	-5.83%	6.86%	-7.88%	5.11%	-0.51%	3.80%	-7.43%
EBITDA Q/Q Growth	133.89%	-12.94%	-370.80%	1.48%	-17.18%	213.29%	-192.86%	102.63%	-31.53%	109.69%	-705.82%
EBIT Q/Q Growth	112.43%	-10.22%	-1,001.96%	4.08%	-37.18%	133.33%	-439.71%	950.00%	-125.00%	102.61%	-1,257.55%
NOPAT Q/Q Growth	107.64%	-10.17%	-5,397.80%	-125.54%	-75.02%	155.82%	-211.75%	10,659.01%	98.85%	85.71%	-993.13%
Net Income Q/Q Growth	104.44%	13.54%	-12,275.00%	-123.53%	-76.39%	127.07%	-412.94%	469.57%	-53.33%	98.61%	-1,575.34%
EPS Q/Q Growth	104.78%	15.04%	-12,200.00%	-122.22%	-71.88%	125.60%	-412.50%	544.44%	-50.00%	98.80%	-1,573.53%
Operating Cash Flow Q/Q Growth	-91.95%	-38.30%	-32.21%	732.00%	-84.38%	19.40%	28.85%	595.24%	-114.79%	30.28%	-36.99%
Free Cash Flow Firm Q/Q Growth	24.19%	188.32%	-48.70%	39.43%	9.58%	1,160.76%	-103.35%	-7.14%	-0.85%	50.06%	40.43%
Invested Capital Q/Q Growth	3.70%	-13.72%	-9.68%	-3.42%	-0.41%	0.51%	-8.30%	0.57%	1.61%	4.09%	-20.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.01%	49.28%	52.05%	51.93%	53.10%	51.58%	52.27%	53.50%	53.07%	52.59%	53.64%
EBITDA Margin	16.15%	-46.30%	-39.01%	13.92%	14.17%	16.01%	-15.10%	14.98%	7.77%	11.29%	-120.91%
Operating Margin	7.17%	-56.24%	-48.58%	5.08%	4.41%	7.21%	-24.92%	7.78%	-0.20%	6.61%	-128.62%
EBIT Margin	7.17%	-56.02%	-48.37%	5.18%	5.14%	7.61%	-24.39%	6.61%	-0.82%	3.26%	-129.57%
Profit (Net Income) Margin	2.16%	-47.29%	-52.05%	-0.41%	1.78%	7.11%	-28.09%	8.27%	-2.35%	-1.53%	-113.73%
Tax Burden Percent	43.18%	81.84%	103.56%	-11.76%	54.84%	126.32%	106.40%	184.78%	82.14%	-187.50%	86.78%
Interest Burden Percent	69.84%	103.16%	103.91%	66.67%	63.27%	74.03%	108.23%	67.65%	350.00%	25.00%	101.14%
Effective Tax Rate	56.82%	0.00%	0.00%	111.76%	45.16%	-26.32%	0.00%	-84.78%	0.00%	287.50%	0.00%
Return on Invested Capital (ROIC)	2.56%	-33.62%	-28.03%	-0.45%	1.81%	6.90%	-13.42%	9.42%	-0.09%	-8.01%	-60.46%
ROIC Less NNEP Spread (ROIC-NNEP)	2.12%	-37.55%	-37.56%	-0.34%	1.48%	5.70%	-19.63%	5.80%	-1.26%	-1.60%	-73.82%
Return on Net Nonoperating Assets (RNNOA)	1.50%	-26.15%	-23.08%	-0.18%	0.78%	2.70%	-9.12%	2.36%	-0.55%	-0.61%	-28.59%
Return on Equity (ROE)	4.06%	-59.77%	-51.11%	-0.63%	2.59%	9.60%	-22.55%	11.78%	-0.64%	-8.61%	-89.05%
Cash Return on Invested Capital (CROIC)	11.32%	14.78%	9.15%	11.07%	7.45%	4.84%	1.21%	4.02%	8.30%	11.63%	18.24%
Operating Return on Assets (OROA)	4.05%	-32.38%	-27.29%	2.78%	2.74%	4.02%	-13.04%	3.14%	-0.38%	1.51%	-62.31%
Return on Assets (ROA)	1.22%	-27.34%	-29.36%	-0.22%	0.95%	3.76%	-15.02%	3.92%	-1.10%	-0.71%	-54.69%
Return on Common Equity (ROCE)	4.06%	-59.74%	-51.16%	-0.63%	2.59%	9.60%	-22.56%	11.79%	-0.64%	-8.61%	-89.01%
Return on Equity Simple (ROE_SIMPLE)	-45.17%	0.00%	-16.46%	-5.91%	-2.82%	0.00%	-6.49%	-27.79%	-28.62%	0.00%	-22.59%
Net Operating Profit after Tax (NOPAT)	27	-356	-323	-5.88	23	92	-165	148	-1.40	-122	-853
NOPAT Margin	3.09%	-39.37%	-34.01%	-0.60%	2.42%	9.11%	-17.44%	14.38%	-0.14%	-12.40%	-90.03%
Net Nonoperating Expense Percent (NNEP)	0.44%	3.93%	9.53%	-0.10%	0.33%	1.20%	6.21%	3.62%	1.17%	-6.41%	13.36%
Return On Investment Capital (ROIC_SIMPLE)	0.63%	-8.74%	-	-	-	1.70%	-	-	-	-2.12%	-
Cost of Revenue to Revenue	46.99%	50.72%	47.95%	48.07%	46.90%	48.42%	47.73%	46.50%	46.93%	47.41%	46.36%
SG&A Expenses to Revenue	40.73%	44.31%	41.01%	40.55%	43.55%	40.42%	39.28%	40.47%	42.54%	40.90%	42.34%
R&D to Revenue	4.10%	4.64%	4.21%	4.17%	4.41%	4.25%	4.86%	4.77%	4.70%	4.37%	4.33%
Operating Expenses to Revenue	45.85%	105.52%	100.63%	46.85%	48.69%	44.37%	77.19%	45.72%	53.27%	45.98%	182.26%
Earnings before Interest and Taxes (EBIT)	63	-507	-460	51	49	77	-231	68	-8.00	32	-1,227
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	142	-419	-371	137	135	162	-143	154	76	111	-1,145
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.48	1.94	2.20	1.69	2.10	2.23	2.10	2.25	2.27	1.72	1.66
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.80	0.99	1.41	1.33	1.74	1.85	1.80	2.12	2.10	1.67	1.48
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	4.28%	3.37%	2.29%	2.41%	1.76%	1.61%	1.63%	1.35%	1.34%	1.64%	1.76%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.24	1.48	1.68	1.43	1.71	1.80	1.73	1.84	1.84	1.51	1.46
Enterprise Value to Revenue (EV/Rev)	1.32	1.49	1.90	1.79	2.19	2.30	2.22	2.58	2.57	2.08	1.87
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	117.55	24.03	28.05	36.68	44.23	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.08	12.23	13.87	13.27	20.42	24.23	24.39	30.37	25.07	15.76	12.64
Enterprise Value to Free Cash Flow (EV/FCFF)	9.64	8.58	17.10	12.15	22.02	36.03	141.47	42.00	19.98	11.54	6.87
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.16	1.10	0.89	0.69	0.64	0.64	0.59	0.57	0.59	0.51	0.55
Long-Term Debt to Equity	0.79	0.82	0.72	0.57	0.54	0.55	0.53	0.50	0.51	0.48	0.48
Financial Leverage	0.71	0.70	0.61	0.54	0.53	0.47	0.46	0.41	0.43	0.38	0.39
Leverage Ratio	2.50	2.51	2.36	2.15	2.15	2.11	2.11	1.94	1.98	1.92	1.94
Compound Leverage Factor	1.75	2.58	2.45	1.43	1.36	1.56	2.28	1.31	6.93	0.48	1.96
Debt to Total Capital	53.74%	52.35%	47.10%	40.65%	39.08%	39.14%	37.12%	36.22%	37.23%	33.77%	35.43%
Short-Term Debt to Total Capital	17.08%	13.46%	8.97%	7.01%	6.41%	5.95%	3.49%	4.50%	5.45%	2.05%	4.40%
Long-Term Debt to Total Capital	36.66%	38.89%	38.13%	33.64%	32.67%	33.19%	33.63%	31.72%	31.78%	31.72%	31.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.02%	-0.02%	0.00%	0.00%	0.02%	-0.07%	-0.07%	-0.05%	0.02%	0.02%
Common Equity to Total Capital	46.26%	47.62%	52.92%	59.35%	60.92%	60.85%	62.95%	63.85%	62.82%	66.21%	64.55%
Debt to EBITDA	-4.57	-4.12	35.19	7.21	6.79	8.51	10.05	-2.61	-2.81	-2.94	-3.86
Net Debt to EBITDA	-3.79	-3.60	30.49	6.25	5.84	7.16	8.49	-2.25	-2.39	-2.39	-3.04
Long-Term Debt to EBITDA	-3.12	-3.06	28.49	5.97	5.67	7.21	9.11	-2.29	-2.40	-2.76	-3.38
Debt to NOPAT	-3.89	-3.47	-10.66	-42.23	-72.82	-35.60	-30.57	-2.79	-2.98	-2.96	-3.41
Net Debt to NOPAT	-3.23	-3.03	-9.24	-36.62	-62.68	-29.98	-25.82	-2.40	-2.54	-2.41	-2.69
Long-Term Debt to NOPAT	-2.65	-2.58	-8.63	-34.95	-60.87	-30.18	-27.70	-2.45	-2.54	-2.78	-2.99
Altman Z-Score	0.93	0.79	1.14	1.51	1.77	1.78	1.70	2.00	1.90	1.75	1.11
Noncontrolling Interest Sharing Ratio	0.00%	0.04%	-0.09%	-0.06%	-0.04%	0.03%	-0.04%	-0.04%	-0.02%	0.02%	0.05%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.10	1.10	1.25	1.33	1.43	1.38	1.57	1.51	1.41	1.62	1.50
Quick Ratio	0.56	0.52	0.63	0.66	0.71	0.72	0.79	0.76	0.71	0.85	0.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,137	916	318	619	444	405	-38	1,142	1,230	1,240	826
Operating Cash Flow to CapEx	38.89%	170.59%	327.91%	400.00%	73.53%	400.00%	362.16%	315.15%	-53.85%	443.75%	340.63%
Free Cash Flow to Firm to Interest Expense	59.85	57.23	17.64	36.42	24.67	20.26	-2.01	51.90	61.48	51.67	59.03
Operating Cash Flow to Interest Expense	0.37	5.44	7.83	12.24	1.39	8.00	7.05	4.73	-1.05	5.92	7.79
Operating Cash Flow Less CapEx to Interest Expense	-0.58	2.25	5.44	9.18	-0.50	6.00	5.11	3.23	-3.00	4.58	5.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.56	0.58	0.56	0.54	0.53	0.53	0.53	0.47	0.47	0.46	0.48
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	2.94	3.09	2.94	2.94	2.94	3.00	2.98	2.98	2.98	3.14	3.21
Fixed Asset Turnover	4.73	4.84	4.97	4.99	5.08	5.08	5.37	5.19	5.10	5.11	5.44
Accounts Payable Turnover	6.49	6.72	6.68	6.75	6.84	6.43	6.96	6.65	6.64	6.64	6.75
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	124.13	118.15	124.21	123.99	124.34	121.50	122.29	122.66	122.48	116.11	113.81
Days Payable Outstanding (DPO)	56.24	54.30	54.67	54.10	53.37	56.72	52.44	54.89	54.97	55.00	54.11
Cash Conversion Cycle (CCC)	67.89	63.85	69.54	69.88	70.97	64.78	69.85	67.77	67.50	61.10	59.70
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,947	3,806	4,411	4,884	5,057	5,078	5,052	5,509	5,478	5,391	5,179
Invested Capital Turnover	0.83	0.85	0.82	0.75	0.75	0.76	0.77	0.66	0.65	0.65	0.67
Increase / (Decrease) in Invested Capital	-1,110	-1,272	-641	-625	-421	-313	-127	-994	-1,231	-1,362	-1,679
Enterprise Value (EV)	4,910	5,637	7,405	6,992	8,638	9,134	8,757	10,144	10,105	8,148	7,548
Market Capitalization	2,973	3,773	5,485	5,172	6,839	7,349	7,080	8,341	8,268	6,568	5,982
Book Value per Share	$10.10	$9.77	$12.29	$14.76	$15.71	$15.54	$15.94	$17.44	$16.91	$17.73	$16.61
Tangible Book Value per Share	($4.19)	($4.34)	($4.85)	($4.26)	($3.67)	($4.01)	($3.35)	($3.79)	($4.28)	($3.63)	($3.89)
Total Capital	4,345	4,078	4,707	5,163	5,348	5,412	5,361	5,804	5,796	5,756	5,597
Total Debt	2,335	2,135	2,217	2,099	2,090	2,118	1,990	2,102	2,158	1,944	1,983
Total Long-Term Debt	1,593	1,586	1,795	1,737	1,747	1,796	1,803	1,841	1,842	1,826	1,737
Net Debt	1,937	1,863	1,921	1,820	1,799	1,784	1,681	1,807	1,840	1,579	1,565
Capital Expenditures (CapEx)	18	51	43	52	34	40	37	33	39	32	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	529	434	505	518	624	536	573	615	567	476	471
Debt-free Net Working Capital (DFNWC)	927	706	801	797	915	870	882	910	885	841	889
Net Working Capital (NWC)	185	157	379	435	572	548	695	649	569	723	643
Net Nonoperating Expense (NNE)	8.20	72	172	-1.88	6.03	20	101	63	22	-107	224
Net Nonoperating Obligations (NNO)	1,937	1,863	1,921	1,820	1,799	1,784	1,681	1,807	1,840	1,579	1,565
Total Depreciation and Amortization (D&A)	79	88	89	86	86	85	88	86	84	79	82
Debt-free, Cash-free Net Working Capital to Revenue	14.22%	11.44%	12.95%	13.30%	15.84%	13.52%	14.56%	15.63%	14.42%	12.14%	11.65%
Debt-free Net Working Capital to Revenue	24.93%	18.61%	20.54%	20.46%	23.22%	21.94%	22.41%	23.12%	22.51%	21.44%	21.99%
Net Working Capital to Revenue	4.97%	4.14%	9.72%	11.17%	14.52%	13.82%	17.66%	16.49%	14.47%	18.43%	15.91%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.10	($2.09)	($2.46)	($0.02)	$0.09	$0.31	($1.25)	$0.41	($0.09)	($0.06)	($5.01)
Adjusted Weighted Average Basic Shares Outstanding	199.10M	203.20M	201M	205.60M	207.40M	212M	211.80M	211.90M	214.50M	215.50M	214.90M
Adjusted Diluted Earnings per Share	$0.10	($2.09)	($2.46)	($0.02)	$0.09	$0.32	($1.25)	$0.40	($0.09)	($0.06)	($5.01)
Adjusted Weighted Average Diluted Shares Outstanding	199.80M	203.20M	201M	205.60M	208.50M	212M	211.80M	213.10M	214.50M	215.50M	214.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	199.29M	198.99M	198.78M	202.71M	207.63M	207.36M	211.86M	211.72M	212.48M	215.36M	214.91M
Normalized Net Operating Profit after Tax (NOPAT)	50	2.10	46	50	27	49	54	60	40	46	46
Normalized NOPAT Margin	5.73%	0.23%	4.78%	5.05%	2.82%	4.84%	5.69%	5.79%	4.08%	4.70%	4.88%
Pre Tax Income Margin	5.01%	-57.79%	-50.26%	3.46%	3.25%	5.63%	-26.40%	4.47%	-2.86%	0.81%	-131.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.32	-31.69	-25.56	3.00	2.72	3.85	-12.16	3.09	-0.40	1.33	-87.64
NOPAT to Interest Expense	1.43	-22.27	-17.97	-0.35	1.28	4.61	-8.69	6.72	-0.07	-5.08	-60.90
EBIT Less CapEx to Interest Expense	2.37	-34.88	-27.94	-0.06	0.83	1.85	-14.11	1.59	-2.35	0.00	-89.93
NOPAT Less CapEx to Interest Expense	0.48	-25.46	-20.36	-3.40	-0.61	2.61	-10.64	5.22	-2.02	-6.41	-63.19
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-14.21%	-13.85%	-30.49%	-66.85%	-128.26%	-87.88%	-51.14%	-10.68%	-10.27%	-10.95%	-12.50%
Augmented Payout Ratio	-14.21%	-41.32%	-128.05%	-232.60%	-291.30%	-315.15%	-119.63%	-25.24%	-24.66%	-26.74%	-44.36%

Frequently Asked Questions About DENTSPLY SIRONA's Financials

When does DENTSPLY SIRONA's financial year end?

According to the most recent income statement we have on file, DENTSPLY SIRONA's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has DENTSPLY SIRONA's net income changed over the last 9 years?

DENTSPLY SIRONA's net income appears to be on an upward trend, with a most recent value of -$910 million in 2024, falling from $251.10 million in 2015. The previous period was -$132 million in 2023. Find out what analysts predict for DENTSPLY SIRONA in the coming months.

What is DENTSPLY SIRONA's operating income?

DENTSPLY SIRONA's total operating income in 2024 was -$879 million, based on the following breakdown:

Total Gross Profit: $1.96 billion
Total Operating Expenses: $2.84 billion

How has DENTSPLY SIRONA revenue changed over the last 9 years?

Over the last 9 years, DENTSPLY SIRONA's total revenue changed from $2.67 billion in 2015 to $3.79 billion in 2024, a change of 41.8%.

How much debt does DENTSPLY SIRONA have?

DENTSPLY SIRONA's total liabilities were at $3.81 billion at the end of 2024, a 6.5% decrease from 2023, and a 84.6% increase since 2015.

How much cash does DENTSPLY SIRONA have?

In the past 9 years, DENTSPLY SIRONA's cash and equivalents has ranged from $272 million in 2024 to $438 million in 2020, and is currently $272 million as of their latest financial filing in 2024.

How has DENTSPLY SIRONA's book value per share changed over the last 9 years?

Over the last 9 years, DENTSPLY SIRONA's book value per share changed from 16.72 in 2015 to 9.77 in 2024, a change of -41.6%.

Related Companies

This page (NASDAQ:XRAY) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Financials

Frequently Asked Questions About DENTSPLY SIRONA's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Financials

Annual Income Statements for DENTSPLY SIRONA

Quarterly Income Statements for DENTSPLY SIRONA

Annual Cash Flow Statements for DENTSPLY SIRONA

Quarterly Cash Flow Statements for DENTSPLY SIRONA

Annual Balance Sheets for DENTSPLY SIRONA

Quarterly Balance Sheets for DENTSPLY SIRONA

Annual Metrics And Ratios for DENTSPLY SIRONA

Quarterly Metrics And Ratios for DENTSPLY SIRONA

Frequently Asked Questions About DENTSPLY SIRONA's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools